ANGLE plc (LON:AGL – Get Free Report) shares passed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of GBX 2.35 and traded as low as GBX 2.33. ANGLE shares last traded at GBX 2.35, with a volume of 1,682,496 shares traded.
ANGLE Stock Performance
The firm’s 50 day moving average is GBX 2.35 and its two-hundred day moving average is GBX 4.01. The stock has a market capitalization of £7.58 million, a PE ratio of -0.49 and a beta of 0.22. The company has a debt-to-equity ratio of 17.22, a quick ratio of 6.18 and a current ratio of 5.19.
ANGLE Company Profile
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD. ANGLE plc has a partnership agreement with Bio View Ltd to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was founded in 1994 and is based in Guildford, the United Kingdom.
Further Reading
- Five stocks we like better than ANGLE
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- This stock gets a 94 out of 100
- Punch these codes into your ordinary brokerage account
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.
